West Pharmaceutical Services Operating Income 2010-2024 | WST

West Pharmaceutical Services operating income for the twelve months ending September 30, 2024 was $0.571B, a 11.41% decline year-over-year.

  • West Pharmaceutical Services annual operating income for 2023 was $0.676B, a 7.9% decline from 2022.
  • West Pharmaceutical Services annual operating income for 2022 was $0.734B, a 2.43% decline from 2021.
  • West Pharmaceutical Services annual operating income for 2021 was $0.752B, a 84.89% increase from 2020.

West Pharmaceutical Services Operating Income 2010-2024 | WST

  • West Pharmaceutical Services annual operating income for 2023 was $0.676B, a 7.9% decline from 2022.
  • West Pharmaceutical Services annual operating income for 2022 was $0.734B, a 2.43% decline from 2021.
  • West Pharmaceutical Services annual operating income for 2021 was $0.752B, a 84.89% increase from 2020.
Related Stocks
Company NameMarket
Cap
McKesson (MCK)$79.1B
Becton Dickinson (BDX)$64.7B
Cardinal Health (CAH)$29.5B
Cooper (COO)$20.1B
Labcorp (LH)$20B
Align Technology (ALGN)$16.9B
Henry Schein (HSIC)$9.4B
Merit Medical Systems (MMSI)$6.1B
DENTSPLY SIRONA (XRAY)$3.7B
CONMED (CNMD)$2.3B
Patterson (PDCO)$1.8B
STAAR Surgical (STAA)$1.3B
Lifevantage (LFVN)$178M
Pro-Dex (PDEX)$152M